CN1883575A - Chinese medicine for treating hyperosteogeny - Google Patents
Chinese medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1883575A CN1883575A CNA2006100178283A CN200610017828A CN1883575A CN 1883575 A CN1883575 A CN 1883575A CN A2006100178283 A CNA2006100178283 A CN A2006100178283A CN 200610017828 A CN200610017828 A CN 200610017828A CN 1883575 A CN1883575 A CN 1883575A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- eupolyphaga
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal preparation for treating hyperosteogeny, which is prepared from the following raw material constituents (by weight ratio): black-tail snake 55-75 parts, herb of garden balsam 36-46 parts, Clematis chinensis 70-82 parts, buck grass 35-46 parts, Loranthus mulberry mistletoe 15-20 parts, myrrh 18-25 parts, frank incense 18-25 parts, dried body of ground beetle 30-45 parts, cyathula root 15-25 parts, spatholobus stem 15-25 parts, frank incense 18-25 parts, ledebouriella root 18-26 parts and Chinese angelica root 19-23 parts.
Description
Technical field
The present invention relates to the field of Chinese medicines, especially relate to a kind of Chinese medicine for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is common in patient's cervical vertebra, joint parts such as lumbar vertebra, though the normal adult performance that all degree is different has hyperosteogeny, it is osteoarticular physiological degeneration variation in person in middle and old age's period, it is the inevitable outcome of human senility, but there are many hyperosteogenys but to belong to pathological proliferation, the lighter is obstructed owing to the QI and blood passages through which vital energy circulates, move not smooth, cause neck, shoulder, waist, have a pain in the leg, weight person can oppress extremity, causes the upper and lower extremities numbness, can not walk, bring misery for patient and its household, traditional treatment generally adopts Dressed plaster, traction, acupuncture, small needle knife etc., these methods are long the course of treatment, the expense height but can only be alleviated slight illness, can not tackle the problem at its root.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine that can effectively treat hyperosteogeny.
For achieving the above object, the present invention can take following technical proposals:
The Chinese medicine of treatment hyperosteogeny of the present invention is characterized in that: it is to be prepared from according to the following weight parts proportioning by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Zaocys 55-75 part; Herba speranskiae tuberculatae 36-46 part; Radix Clematidis 70-82 part; Herba Lycopodii 35-46 part, Herba Taxilli 15-20 part; Myrrha 18-25 part; Olibanum 18-25 part; Eupolyphaga 30-45 part; Radix Cyathulae 15-25 part; Caulis Spatholobi 15-25 part; Lignum Dalbergiae Odoriferae 18-25 part; Radix Saposhnikoviae 18-26 part; Radix Angelicae Sinensis 19-23 part.
The weight portion proportioning of described crude drug is:
55 parts of Zaocyss; Herba speranskiae tuberculatae 36; 70 parts of Radix Clematidis; 35 parts of Herba Lycopodiis, 15 parts of Herba Taxillis; 18 parts of Myrrhas; 18 parts of Olibanums; 30 parts of eupolyphaga; 15 parts of Radix Cyathulaes; 15 parts of Caulis Spatholobis; 18 parts of Lignum Dalbergiae Odoriferaes; 18 parts of Radix Saposhnikoviaes; 19 parts of Radix Angelicae Sinensis.
The weight portion proportioning of described crude drug can be:
60 parts of Zaocyss; Herba speranskiae tuberculatae 38; 73 parts of Radix Clematidis; 37 parts of Herba Lycopodiis, 17 parts of Herba Taxillis; 20 parts of Myrrhas; 20 parts of Olibanums; 34 parts of eupolyphaga; 18 parts of Radix Cyathulaes; 18 parts of Caulis Spatholobis; 20 parts of Lignum Dalbergiae Odoriferaes; 20 parts of Radix Saposhnikoviaes; 20 parts of Radix Angelicae Sinensis.
The weight portion proportioning of described crude drug also can be:
65 parts of Zaocyss; Herba speranskiae tuberculatae 41; 75 parts of Radix Clematidis; 40 parts of Herba Lycopodiis, 18 parts of Herba Taxillis; 22 parts of Myrrhas; 22 parts of Olibanums; 38 parts of eupolyphaga; 20 parts of Radix Cyathulaes; 20 parts of Caulis Spatholobis; 22 parts of Lignum Dalbergiae Odoriferaes; 22 parts of Radix Saposhnikoviaes; 21 parts of Radix Angelicae Sinensis.
The weight portion proportioning of described crude drug can be again:
70 parts of Zaocyss; Herba speranskiae tuberculatae 44; 79 parts of Radix Clematidis; 43 parts of Herba Lycopodiis, 19 parts of Herba Taxillis; 24 parts of Myrrhas; 24 parts of Olibanums; 42 parts of eupolyphaga; 22 parts of Radix Cyathulaes; 22 parts of Caulis Spatholobis; 24 parts of Lignum Dalbergiae Odoriferaes; 24 parts of Radix Saposhnikoviaes; 22 parts of Radix Angelicae Sinensis.
The weight portion proportioning of described crude drug also can be:
75 parts of Zaocyss; Herba speranskiae tuberculatae 46; 82 parts of Radix Clematidis; 46 parts of Herba Lycopodiis, 20 parts of Herba Taxillis; 25 parts of Myrrhas; 25 parts of Olibanums; 45 parts of eupolyphaga; 25 parts of Radix Cyathulaes; 25 parts of Caulis Spatholobis; 25 parts of Lignum Dalbergiae Odoriferaes; 26 parts of Radix Saposhnikoviaes; 23 parts of Radix Angelicae Sinensis.
The Chinese medicine of treatment hyperosteogeny of the present invention, it is to be prepared from according to following method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
The invention has the advantages that this Chinese medicine preparation is according to Traditional Chinese medical theory, select natural Chinese medicine for use, utilize the expelling wind and removing dampness of Zaocys, Radix Clematidis, Herba speranskiae tuberculatae, Herba Lycopodii, the function of promoting blood circulation to restore menstrual flow; The Herba Taxilli liver and kidney tonifying, Olibanum, Myrrha promoting blood circulation and stopping pain, eupolyphaga removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones, the effect of Radix Cyathulae, Caulis Spatholobi promoting blood flow to regulate menstruation; The promoting blood circulation to remove blood stasis of Lignum Dalbergiae Odoriferae, the cold expelling of regulating the flow of vital energy, pain relieving appetizing and Radix Angelicae Sinensis, Radix Saposhnikoviae set upright effect, make its effective wind-damp dispelling, the meridian dredging, liver and kidney tonifying, blood circulation promoting and blood stasis dispelling, softening the hard mass pain relieving, thoroughly eradicate patient's initial stage neck, shoulder, waist, have a pain in the leg and when developing into the later stage because hyperosteogeny influence the numb limbs and tense tendons of patient's live and work, the difficult symptom of walking.
The instructions of taking of this Chinese medicine preparation is: day clothes two to three times, and each 3-5 gram (adorning 1 gram in the general capsule), 30 days is a course of treatment.The patient of mild (no hypertrophy shape) takes 1-3 the course of treatment and can fully recover; Cervical vertebra, lumbar vertebra have an outgrowth patient of joint, and then can fully recover 3-4 the course of treatment.For the patient of hypertrophy serious symptom, need proper extension medicine time.The effect of this Chinese medicine can be found out by following table:
| Total number of persons | Effectively | Recovery from illness | Invalid | Effective percentage % | Cure rate | |
| Hyperosteogeny | 122 | 120 | 100 | 2 | 98 | 82 |
| Hyperosteogeny | 96 | 93 | 80 | 3 | 97 | 83 |
Because what the present invention adopted is pure Chinese crude drug preparation, has no side effect, take stomach non-stimulatedly for a long time, can not cause patient's difficulty of taking medicine, can guarantee its therapeutic effect; Moreover the medical material that this Chinese medicine is selected for use is common medical material, and whole formulation cost is low, and general patient can both be accepted, and can not increase the cost of curing the disease of patient family.
The specific embodiment
Embodiment 1:
The Chinese medicine of treatment hyperosteogeny of the present invention, it is to be prepared from according to following weight parts proportioning and method by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Proportioning: 55 parts of Zaocyss; Herba speranskiae tuberculatae 36; 70 parts of Radix Clematidis; 35 parts of Herba Lycopodiis, 15 parts of Herba Taxillis; 18 parts of Myrrhas; 18 parts of Olibanums; 30 parts of eupolyphaga; 15 parts of Radix Cyathulaes; 15 parts of Caulis Spatholobis; 18 parts of Lignum Dalbergiae Odoriferaes; 18 parts of Radix Saposhnikoviaes; 19 parts of Radix Angelicae Sinensis.
Method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
Embodiment 2:
The Chinese medicine of treatment hyperosteogeny of the present invention, it is to be prepared from according to following weight parts proportioning and method by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Proportioning: 60 parts of Zaocyss; Herba speranskiae tuberculatae 38; 73 parts of Radix Clematidis; 37 parts of Herba Lycopodiis, 17 parts of Herba Taxillis; 20 parts of Myrrhas; 20 parts of Olibanums; 34 parts of eupolyphaga; 18 parts of Radix Cyathulaes; 18 parts of Caulis Spatholobis; 20 parts of Lignum Dalbergiae Odoriferaes; 20 parts of Radix Saposhnikoviaes; 20 parts of Radix Angelicae Sinensis.
Method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
Embodiment 3:
The Chinese medicine of treatment hyperosteogeny of the present invention, it is to be prepared from according to following weight parts proportioning and method by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Proportioning: 65 parts of Zaocyss; Herba speranskiae tuberculatae 41; 75 parts of Radix Clematidis; 40 parts of Herba Lycopodiis, 18 parts of Herba Taxillis; 22 parts of Myrrhas; 22 parts of Olibanums; 38 parts of eupolyphaga; 20 parts of Radix Cyathulaes; 20 parts of Caulis Spatholobis; 22 parts of Lignum Dalbergiae Odoriferaes; 22 parts of Radix Saposhnikoviaes; 21 parts of Radix Angelicae Sinensis.
Method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
Embodiment 4:
The Chinese medicine of treatment hyperosteogeny of the present invention, it is to be prepared from according to following weight parts proportioning and method by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Proportioning: 70 parts of Zaocyss; Herba speranskiae tuberculatae 44; 79 parts of Radix Clematidis; 43 parts of Herba Lycopodiis, 19 parts of Herba Taxillis; 24 parts of Myrrhas; 24 parts of Olibanums; 42 parts of eupolyphaga; 22 parts of Radix Cyathulaes; 22 parts of Caulis Spatholobis; 24 parts of Lignum Dalbergiae Odoriferaes; 24 parts of Radix Saposhnikoviaes; 22 parts of Radix Angelicae Sinensis.
Method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
Embodiment 5:
The Chinese medicine of treatment hyperosteogeny of the present invention, it is to be prepared from according to following weight parts proportioning and method by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Proportioning: 75 parts of Zaocyss; Herba speranskiae tuberculatae 46; 82 parts of Radix Clematidis; 46 parts of Herba Lycopodiis, 20 parts of Herba Taxillis; 25 parts of Myrrhas; 25 parts of Olibanums; 45 parts of eupolyphaga; 25 parts of Radix Cyathulaes; 25 parts of Caulis Spatholobis; 25 parts of Lignum Dalbergiae Odoriferaes; 26 parts of Radix Saposhnikoviaes; 23 parts of Radix Angelicae Sinensis.
Method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
Claims (7)
1, a kind of Chinese medicine for the treatment of hyperosteogeny is characterized in that: it is to be prepared from according to the following weight parts proportioning by crude drug Zaocys, Herba speranskiae tuberculatae, Radix Clematidis, Herba Lycopodii, Herba Taxilli, Myrrha, Olibanum, eupolyphaga, Radix Cyathulae, Caulis Spatholobi, Lignum Dalbergiae Odoriferae, Radix Saposhnikoviae, Radix Angelicae Sinensis:
Zaocys 55-75 part; Herba speranskiae tuberculatae 36-46 part; Radix Clematidis 70-82 part; Herba Lycopodii 35-46 part, Herba Taxilli 15-20 part; Myrrha 18-25 part; Olibanum 18-25 part; Eupolyphaga 30-45 part; Radix Cyathulae 15-25 part; Caulis Spatholobi 15-25 part; Lignum Dalbergiae Odoriferae 18-25 part; Radix Saposhnikoviae 18-26 part; Radix Angelicae Sinensis 19-23 part.
2, Chinese medicine according to claim 1 is characterized in that: the weight portion proportioning of described crude drug is:
55 parts of Zaocyss; Herba speranskiae tuberculatae 36; 70 parts of Radix Clematidis; 35 parts of Herba Lycopodiis, 15 parts of Herba Taxillis; 18 parts of Myrrhas; 18 parts of Olibanums; 30 parts of eupolyphaga; 15 parts of Radix Cyathulaes; 15 parts of Caulis Spatholobis; 18 parts of Lignum Dalbergiae Odoriferaes; 18 parts of Radix Saposhnikoviaes; 19 parts of Radix Angelicae Sinensis.
3, Chinese medicine according to claim 1 is characterized in that: the weight portion proportioning of described crude drug is:
60 parts of Zaocyss; Herba speranskiae tuberculatae 38; 73 parts of Radix Clematidis; 37 parts of Herba Lycopodiis, 17 parts of Herba Taxillis; 20 parts of Myrrhas; 20 parts of Olibanums; 34 parts of eupolyphaga; 18 parts of Radix Cyathulaes; 18 parts of Caulis Spatholobis; 20 parts of Lignum Dalbergiae Odoriferaes; 20 parts of Radix Saposhnikoviaes; 20 parts of Radix Angelicae Sinensis.
4, Chinese medicine according to claim 1 is characterized in that: the weight portion proportioning of described crude drug is:
65 parts of Zaocyss; Herba speranskiae tuberculatae 41; 75 parts of Radix Clematidis; 40 parts of Herba Lycopodiis, 18 parts of Herba Taxillis; 22 parts of Myrrhas; 22 parts of Olibanums; 38 parts of eupolyphaga; 20 parts of Radix Cyathulaes; 20 parts of Caulis Spatholobis; 22 parts of Lignum Dalbergiae Odoriferaes; 22 parts of Radix Saposhnikoviaes; 21 parts of Radix Angelicae Sinensis.
5, Chinese medicine according to claim 1 is characterized in that: the weight portion proportioning of described crude drug is:
70 parts of Zaocyss; Herba speranskiae tuberculatae 44; 79 parts of Radix Clematidis; 43 parts of Herba Lycopodiis, 19 parts of Herba Taxillis; 24 parts of Myrrhas; 24 parts of Olibanums; 42 parts of eupolyphaga; 22 parts of Radix Cyathulaes; 22 parts of Caulis Spatholobis; 24 parts of Lignum Dalbergiae Odoriferaes; 24 parts of Radix Saposhnikoviaes; 22 parts of Radix Angelicae Sinensis.
6, Chinese medicine according to claim 1 is characterized in that: the weight portion proportioning of described crude drug is:
75 parts of Zaocyss; Herba speranskiae tuberculatae 46; 82 parts of Radix Clematidis; 46 parts of Herba Lycopodiis, 20 parts of Herba Taxillis; 25 parts of Myrrhas; 25 parts of Olibanums; 45 parts of eupolyphaga; 25 parts of Radix Cyathulaes; 25 parts of Caulis Spatholobis; 25 parts of Lignum Dalbergiae Odoriferaes; 26 parts of Radix Saposhnikoviaes; 23 parts of Radix Angelicae Sinensis.
7, Chinese medicine according to claim 1 is characterized in that: it is to be prepared from according to following method:
The first step: with the Zaocys parch of decaptitating; Olibanum is fried to deoiling; Myrrha is fried to burned black; Eupolyphaga is fried to detoxification;
Second step: the medicine of above-mentioned parch and surplus stock medicine are ground into the powder face together incapsulate and get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100178283A CN100372551C (en) | 2006-05-25 | 2006-05-25 | Chinese medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100178283A CN100372551C (en) | 2006-05-25 | 2006-05-25 | Chinese medicine for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1883575A true CN1883575A (en) | 2006-12-27 |
| CN100372551C CN100372551C (en) | 2008-03-05 |
Family
ID=37581957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100178283A Expired - Fee Related CN100372551C (en) | 2006-05-25 | 2006-05-25 | Chinese medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100372551C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600272A (en) * | 2012-04-11 | 2012-07-25 | 苏贵安 | Traditional Chinese medicine for treatment of orthopedic disease |
| CN106727955A (en) * | 2017-01-12 | 2017-05-31 | 潘培兰 | A kind of Chinese medicine composition |
| CN107468896A (en) * | 2017-07-31 | 2017-12-15 | 马昌豪 | A kind of huoxue zhitong powder, huoxue zhitong san |
| CN110898127A (en) * | 2019-12-11 | 2020-03-24 | 焦作圣泥堂科技有限公司 | A Chinese medicinal composition for treating pain, and its preparation method |
| CN116211921A (en) * | 2023-04-17 | 2023-06-06 | 四川农业大学 | Pharmaceutical composition for treating rheumatic bone pain and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129439C (en) * | 2000-05-22 | 2003-12-03 | 韩世昌 | Hyperosteogeny-treating capsule |
-
2006
- 2006-05-25 CN CNB2006100178283A patent/CN100372551C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600272A (en) * | 2012-04-11 | 2012-07-25 | 苏贵安 | Traditional Chinese medicine for treatment of orthopedic disease |
| CN102600272B (en) * | 2012-04-11 | 2013-10-09 | 苏贵安 | Traditional Chinese medicine for treatment of orthopedic disease |
| CN106727955A (en) * | 2017-01-12 | 2017-05-31 | 潘培兰 | A kind of Chinese medicine composition |
| CN107468896A (en) * | 2017-07-31 | 2017-12-15 | 马昌豪 | A kind of huoxue zhitong powder, huoxue zhitong san |
| CN110898127A (en) * | 2019-12-11 | 2020-03-24 | 焦作圣泥堂科技有限公司 | A Chinese medicinal composition for treating pain, and its preparation method |
| CN116211921A (en) * | 2023-04-17 | 2023-06-06 | 四川农业大学 | Pharmaceutical composition for treating rheumatic bone pain and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100372551C (en) | 2008-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN1883575A (en) | Chinese medicine for treating hyperosteogeny | |
| CN101007040B (en) | External applied medicine for treating bone fractures | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN1883576A (en) | Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion | |
| CN1283309C (en) | Pure medicated wine | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN102228584A (en) | Chinese medicinal preparation for treating helosis | |
| CN100333738C (en) | Chinese medicinal ointment for treating bone diseases | |
| CN1201765C (en) | Chinese medicine ointment for treating arthrosis | |
| CN103301411A (en) | Traditional Chinese medicine wine for treating soft tissue injury and preparation method thereof | |
| CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
| CN1814091A (en) | External-use Chinese medicine preparation for treating angeitis and diabetes foot | |
| CN102772617B (en) | Medicine for treating disease of hyperosteogeny | |
| CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
| CN100349608C (en) | Obstruction dredging medicine pill and its prepn | |
| CN1720938A (en) | Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process | |
| CN1091612C (en) | Homothermal adhesive plaster promoting blood circulation to stop pain | |
| CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN107320539A (en) | Pharmaceutical composition for treating disc herniation | |
| CN1281253C (en) | Chinese traditional medicine for treating disc protrusion and hyperosteogeny | |
| CN106038896A (en) | Bonesetting pain relieving plaster applied to therapy and preparation method of bonesetting pain therapy herb plaster | |
| CN105560537A (en) | Medicine composition for treating osteoartritis and preparation method thereof | |
| CN1230192C (en) | Medicine for treating protrasion of the lumbar intervertebral and preparation method | |
| CN1281255C (en) | Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080305 |